Mersana Therapeutics, Inc. - Product Pipeline Review - H2 2011

Global Markets Direct, December 2011, Pages: 42

Mersana Therapeutics, Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Mersana Therapeutics, Inc. - Product Pipeline Review - H2 2011” provides data on the Mersana Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Mersana Therapeutics, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Mersana Therapeutics, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Mersana Therapeutics, Inc. - Brief Mersana Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Mersana Therapeutics, Inc. human therapeutic divisi

List of Tables
List of Figures
Mersana Therapeutics, Inc. Snapshot
Mersana Therapeutics, Inc. Overview
Key Information
Key Facts
Mersana Therapeutics, Inc. – Research and Development Overview
Key Therapeutic Areas
Mersana Therapeutics, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Mersana Therapeutics, Inc. – Pipeline Products Glance
Mersana Therapeutics, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Mersana Therapeutics, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Mersana Therapeutics, Inc. – Drug Profiles
Antibody-Drug Conjugates
Product Description
Mechanism of Action
R&D Progress
Recombinant Biologic-Based Drugs
Product Description
Mechanism of Action
R&D Progress
XMT-1001
Product Description
Mechanism of

Customers who bought this item also bought

• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Idenix Pharmaceuticals, Inc.
• SAVVIS, Inc.
• Alibaba.com Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
• Maxim Integrated Products, Inc.
• Dell Inc.
• Tektronix, Inc.
• PerkinElmer, Inc.
• Advanced Micro Devices, Inc.
• Analysis of Google Inc